ARCHIVES

Committee Unblinds Phase III Zytiga Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

Cancer Centers Branch To Be ‘More Proactive,’ Kimes Tells NCAB

January 12, 1990

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002

Battelle Wins Big Toxiology Contract

March 22, 1974

Phase III Avastin Trial Fails Primary Endpoints

February 28, 2014

Cancer Rates Keep Falling, NCI’s Progress Report Says.

December 7, 2001

National Policy: IOM Seeks Nominations for Cancer Policy Board

November 29, 1996